Stem Cell Clinic

A.J. Foyt planning to undergo stem-cell therapy – The Indianapolis Star – Indianapolis Star

By adminFebruary 15, 2017Uncategorized

Team owner A.J. Foyt watches his drivers during practice for the Indianapolis 500 on Monday, May 23, 2016, afternoon at the Indianapolis Motor Speedway.(Photo: Matt Kryger/IndyStar)Buy Photo

Racing legend A.J. Foyt is hoping to find the"fountain of youth."

The 82-year-old four-time winner of the Indianapolis 500 toldVerizon IndyCarmedia that he plans to undergo stem-cell therapy to help repair his ankles and shoulder. He also will have stem cells injected into hisblood.

Foyt's body has taken quite a beating over the years. According to the story, he suffered a broken back during a NASCAR race in 1964 and broken feet and legs during a 1991 IndyCar crash. In 2005, hewas stung more than 200 times by bees while trapped under his bulldozer at his Texas ranch. He's had knee and hip replacements, and in 2014 underwent triple-bypass heart surgery.

Foyt will undergo the therapy in Cancun, Mexico, as the treatment is not available in the United States.

It used to be you would have to go to Germany to get this procedure, but now it's available in Cancun and that is probably where I'll have it done, Foyt said Saturday during the Verizon IndyCar Series open test at Phoenix Raceway. I'm not in good health like I used to be and, if my son Larry hadn't taken over (running) the team four years ago, I would have had to shut it down. It's something he likes to do and I'm backing him 100 percent.

I feel better this year than I did last year, Foyt continued. If I get to feeling bad, I probably won't show up at the race. But I'm going to do that stem cell deal. My wife, Lucy, has been pretty sick lately. Dan Pastorini (the former NFL quarterback) did it and it helped him. Peyton Manning (the former Indianapolis Colts and Denver Broncos quarterback) did it for his neck and it really helped him. Tony Dorsett (the former Dallas Cowboys running back) did it, so I think we should try it.

Read the full story at indycar.com.

Autoplay

Show Thumbnails

Show Captions

Excerpt from:
A.J. Foyt planning to undergo stem-cell therapy - The Indianapolis Star - Indianapolis Star

A.J. Foyt planning to undergo stem cell therapy | USA TODAY Sports – USA TODAY

By adminFebruary 15, 2017Stem Cell Treatment

A.J. Foyt during practice for the 2016 Indianapolis 500. (The Indianapolis Star)

Auto racing legend A.J. Foyt is hoping to find thefountain of youth for a body that has taken quite a beating over the years. And like a handful of athletes before him, its a journey that will take him outside the United States.

Foyt, 82, told IndyCar.com Saturday during a Verizon IndyCar Series test at Phoenix International Raceway that he plans to undergo stem cell therapy, likely in Cancun, Mexico, with injections into both ankles and shoulders as well as his blood.

Foyt suffered a broken back during a NASCAR race in 1964 and broken feet and legs during a 1991 IndyCar crash. In 2005, hewas stung more than 200 times by bees while trapped under his bulldozer at his Texas ranch. Hes had knee and hip replacements, and in 2014 underwent triple-bypass heart surgery.

Hes hopeful that stem cell therapy will help heal the lingering effects of some of those ailments.

They have to cut away some of the tissue from my stomach and it takes 8-10 weeks for it to grow back to produce the stem cells, Foyt told IndyCar. Ill probably have it done soon so that we can begin the treatment within the next two to three months.

Adult stem cells are able to grow and become a cell for a specific tissue or organ, according to the National Institutes of Health. They are different from embryonic stem cells, which come from fertilized eggs or aborted fetuses. Embryonic stem cells can turn into cells for nearly any tissue in the body.

But the procedure Foyt seeks has not yet been approved by the FDA for use in the United States, so he will head south of the border where several former football players have received these treatments.

MORE:Companies offer athletes hope with questionable stem cell treatments

It used to be you would have to go to Germany to get this procedure, but now its available in Cancun and that is probably where Ill have it done, Foyt said. Dan Pastorini (the former NFL quarterback) did it and it helped him. Peyton Manning (the former Indianapolis Colts and Denver Broncos quarterback) did it for his neck and it really helped him. Tony Dorsett (the former Dallas Cowboys running back) did it, so I think we should try it.

Dorsett underwent a procedure where stem cells were extracted from his own stomach fat then cultured and multiplied with the help of a serum derived from cattle. The cells were then purified and injected back into him, about 200 million at a time, in Cancun.

When I was taking the stem cells, I was able to figure things out a little better and not get as frustrated, Dorsett told USA TODAY Sports in November of 2015. But Dorsett also admitted the effects of the therapy faded over time.

Stem cell treatments are largely untested and unproven by U.S. standards. In general, the FDA has a critical threshold for adult stem cell therapies.

If the cells are more than minimally manipulated when extracted from a patients body, they are classified as biological drugs that must go through long and costly testing to make sure they are safe and effective for widespread use in the USA.

Contributing:Brent Schrotenboer and Jarrett Bell

More:
A.J. Foyt planning to undergo stem cell therapy | USA TODAY Sports - USA TODAY

Paralyzed Easton Teen Seeking Stem Cell Treatment In Bid To … – Wilton Daily Voice

By adminFebruary 15, 2017Stem Cell Treatment

EASTON, Conn. --Hope is a big word in the Standen household in Easton these days.

Through a procedure at the Cell Medicine Institute in Panama, there is a 60 percent to 70 percent chance that Zach Standen a 17-year-old who became paralyzed from the waist down after a car accident last summer may regain some feeling and movement in his legs.

In the procedure, The stem cells are taken from your own bone marrow and human umbilical cords and are re-injected into your body," Zachs mother, Christine Standen, said in a phone interview.

The ultimate goal is for the stem cells from Zach's body to regenerate the nerves and neural connections for him to regain some feeling and function in his legs.

It's extremely important that Zach gets the treatment as soon as possible, his mother said. "He should get the stem cell therapy within a year of the accident since this is when the most healing occurs and before scar tissue is laid down," Christine Standen said. Once this happens, she said, muscle mass is lost and muscles begin to atrophy.

Related story: Easton teen is left paralyzed after car crash.

Zach's family has set up a GoFundMe page to raise the nearly $40,000 needed to pay for the treatment. So far, the page has been shared 687 times. With 313 donations, it has raised $18,194 out of a $100,000 goal.

The family is hoping to raise enough money to get Zach two stem cell treatments, which would greatly increase his chances for recovery.

In addition, a fundraiser has been established to benefit the cause for Zach. Through Feb. 28, a total of 15 percent of the cost of the Arbonne products from this page will be donated to Zach Standens Stem Cell Therapy Fund.

Zach and his mother, as well as Zachs girlfriend, Constance Rude, plan on taking the month-long trip to Panama.

We are hoping that Zach [who attends Joel Barlow High School in Redding] will get his homework assignments ahead of time," she said, adding that he will most likely have to take summer classes or make up some timein the fall.

In a post on Zachs GoFundMe Page, his mother wrote, As of right now, there has been very little progress physically and I can't see him being like this for the rest of his life. No walking, no bowel or bladder control, no sexual function, no feeling. This is no way to live if we can help it, especially for a 17 year old."

She said Zach's spirits are waning. "He is finding it difficult to study and is trying to maintain hope."

Aside from his medical issues, Zach has the life of a typical teenager he goes to school and hangs out with his friends.

Related story: A family seeks support for treatment for paralyzed son.

Zach goes twice a week to physical therapy at Gaylord Hospital in Wallingford. "He is working really hard, every day," said his mother.

Another fundraiser for Zachwill be a concert by the Grayson Hugh & The Moon Hawks & The Bobby Paltauf Band on March 11 at 7 p.m. at the Fairfield Theatre Company. A total of 25 percent of ticket sales will go toward Zach's Stem Cell Therapy Fund.

Christine Standen said she feels extreme gratitude toward for the support the family has received through this tough time. "We are so grateful to the entire community," she said.

For previous Daily Voice articles on Zach Standen, click here and here .

Center to develop stem cell research – Kuwait Times | Kuwait Times – Kuwait Times

By adminFebruary 15, 2017Stell Cell Research

KUWAIT: Sheikha Salwa Al-Sabah Center for Stem Cell and Umbilical Cord will pave the way forward to develop services and researches in the healthcare sector, said Kuwait Holding Projects Company (KIPCO) Yesterday. The center will help advance research within the stem cell and umbilical cord domains and will aid in developing a strong partnership between the public and private sectors within health services, KIPCO Vice Chairman Faisal Hamad Al-Ayyar said in a statement.

Hopefully, this facility will make it easy for the public to access necessary healthcare in Kuwait, said Ayyar who affirmed stem cell and umbilical cord researches will be crucial to the treatment of various Intractable diseases. According to the company, KIPCO and its Group companies will hand over the Sheikha Salwa Sabah Al-Ahmad Stem Cell and Umbilical Cord Center in mid-September 2017, with 70 per cent of the construction of the building now complete. The center, financed through a KD seven million donation made to the Ministry of Health by Masharee Al-Khair Charity Organization on behalf of KIPCO Group, is the Gulf regions first-ever center to be dedicated to stem cell research and the storage of umbilical cords.

The Sheikha Salwa Sabah Al Ahmad Stem Cell and Umbilical Cord Center is being built over a 12,000-square-meters plot of land in the Al Sabah Health Zone, opposite the Maternity Hospital. It has a total built up area of 7,800-square-meters and includes a three-floor main building, a utilities building, in addition to external landscaping and parking. The facility includes testing and research laboratories, blood and cord storage banks, research and medical libraries, as well as a lecture theater. In addition to KD 7 million donation, the Advanced Technology Company, a member of the KIPCO Group, has pledged to provide state-of-the-art equipment for the centers specialized laboratories, cooling systems and stem cell storage facilities. ATCs contribution is valued at KD 1 million. KUNA

Visit link:
Center to develop stem cell research - Kuwait Times | Kuwait Times - Kuwait Times

Leukemia Stem Cell Transplantation | CTCA

By adminFebruary 14, 2017Stem Cell Medical Center

Stem cell transplantation for leukemia

A stem cell transplant can be used to restore healthy bone marrow in patients with leukemia. Stem cells help stimulate new bone marrow growth and restore the immune system.

Before a stem cell transplant for leukemia, you will undergo a conditioning regimen, which involves intensive treatment to destroy as many leukemia cells as possible. You may receive high doses of chemotherapy and, in some cases, radiation therapy. You may also receive reduced-intensity conditioning (a mini-allogeneic transplant), which uses lower, less toxic doses of chemotherapy and/or total body irradiation (TBI) before the transplant.

Once this preparative regimen is complete, you are ready to undergo the transplant. Much like a blood transfusion, youll receive the stem cells intravenously. The procedure takes about an hour. After entering the bloodstream, the stem cells travel to the bone marrow and start to make new blood cells in a process known as engraftment.

In the months following the transplant, your care team will monitor your blood counts. You may need transfusions of red blood cells and platelets. Sometimes, the intensive treatments you receive before the stem cell transplantation for leukemia can cause side effects, like infection. In this case, your doctor may administer IV antibiotics.

If you had an allogeneic stem cell transplant, your doctor may prescribe certain drugs to reduce the risk of graft-versus-host-disease (GVHD), a condition where the donated cells attack the patient's tissues.

Recovery from a leukemia stem cell transplant can take several months. Dr. Redei and his team will work together with the rest of your care team to support you throughout the entire process.

For example, your dietitian will recommend a healthy diet to nutritionally fortify your body, and your naturopathic clinician will recommend natural therapies to help reduce side effects, such as neuropathy. Your rehabilitation therapist will recommend safe levels of physical activity to help you stay active and independent.

Additionally, your pain management practitioner will use various techniques to help alleviate discomfort and control bone and neuropathic pain, while your mind-body therapist will provide counseling and relaxation techniques.

A stem cell transplant (also called hematopoietic progenitor cell transplantation) infuses healthy blood-forming stem cells into the body. Stem cells can be collected from the bone marrow, circulating (peripheral) blood, and umbilical cord blood.

There are two main types of stem cell transplants:

An advantage of an allogeneic transplant is that the stem cells come from a healthy donor with no malignant cells. However, since it can be difficult to find a matching donor, an autologous transplant is usually more common.

The rest is here:
Leukemia Stem Cell Transplantation | CTCA

Ovarian hormones awaken newly discovered breast stem cells – Medical Xpress

By adminFebruary 14, 2017Stem Cell Medical Center

February 13, 2017 Microscopy reveals the tree-like arrangement of the milk-producing cells in the mammary gland during pregnancy. Credit: Dr Anne Rios, Walter and Eliza Hall Institute

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy.

The newly discovered stem cells, which respond to the 'ovarian hormones' progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

The discovery was made by Dr Nai Yang Fu, Dr Anne Rios, Professor Jane Visvader and Professor Geoff Lindeman as part of a 20-year research program into how the breast develops from stem cells, and how breast cancers can arise from stem cells and developing breast tissue. The research was published today in Nature Cell Biology.

Dr Fu said the team had been able to build on their earlier discovery of breast stem cells, by defining subsets of stem cells with different functions, a project that was conducted in collaboration with bioinformatics researchers Dr Matthew Ritchie and Professor Gordon Smyth.

"When we looked at the genes that were switched on in these stem cells, we could distinguish subsets of stem cells that differed in their expression of genes encoding two proteins called Tetraspanin8 and Lgr5," he said. "By looking at the levels of Tetraspanin8 and Lgr5 protein on the surface of the cells, we could divide the stem cells into three separate groups."

The team used advanced technologies including three-dimensional imaging to show that the three groups of stem cells are located in different parts of the breast and function differently, Dr Rios said.

"We focused particularly on one stem cell subtype that had the highest levels of Tetraspanin8 and Lgr5 protein, which were located in the 'proximal' region of the breast around the nipple," Dr Rios said.

Professor Visvader said these stem cells were normally dormant - sitting quietly and not dividing - and remained in the proximal region throughout life. "However, when they were exposed to the hormones progesterone and oestrogen these cells awakened and could rapidly give rise to new breast cells," she said.

The research also revealed that the stem cells with high levels of Tetraspanin8 and Lgr5 protein had many similarities to a subtype of 'triple negative' breast cancers known as claudin-low cancers.

"Compared to other types of breast cancer, claudin-low cancers have a high chance of recurrence after treatment, leading to a poor prognosis for patients" Professor Visvader said.

Professor Lindeman, who is also a medical oncologist at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, said the research may lead to future improved outcomes for people with claudin-low cancers, "We hope that our discovery can be used to understand how cancers may arise from long-lived stem cells, and potentially lead to better outcomes for breast cancer patients in the future," he said.

Explore further: Long-lived breast stem cells could retain cancer legacy

More information: Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive, Nature Cell Biology, nature.com/articles/doi:10.1038/ncb3471

A puzzling question has lurked behind SMA (spinal muscular atrophy), the leading genetic cause of death in infants.

The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, ...

Patients with inflammatory bowel disease are more likely to see dramatic shifts in the make-up of the community of microbes in their gut than healthy people, according to the results of a study published online Feb. 13 in ...

Research led by scientists at UC San Francisco and Case Western Reserve University School of Medicine has used brain "organoids"tiny 3-D models of human organs that scientists grow in a dish to study diseaseto identify ...

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Continue reading here:
Ovarian hormones awaken newly discovered breast stem cells - Medical Xpress

Dr. Oz takes on those bogus for-profit stem cell clinics–and cuts them to shreds – Chicago Tribune

By adminFebruary 14, 2017Stem Cell Clinic

The undercover investigation youre about to see today is going to make you really angry, because were exposing the worst kind of scam one that takes advantage of those most vulnerable, stealing not just their money, but their hope, their dignity.

Thats how Dr. Mehmet Oz introduces a series of segments scheduled to run on his daytime television program Tuesday. His quarry: those for-profit clinics offering supposed stem cell treatments for an implausible host of diseases unproven, unlikelyand very expensive cures.

We reported on this noisome corner of medical pseudo-sciencelast year, outlining theabsence of scientific support for their treatmentand their intensive marketing pitches to hopeful patients. We reported that in a survey of stem cell tourism, stem cell scientist Paul Knoepfler of UC Davis and bioethicist Leigh Turner of the University of Minnesotaidentified 570 clinicsaround the U.S. offering stem cell interventions. Scores were concentrated in such hotspots as Beverly Hills, Phoenixand New York. Many were offering unproven therapies featuring the termstem cell as a marketing veneer.

Dr. Ozs investigation of these clinics is a worthy addition to public awareness. Its must-viewing for patients and families desperate enough to contemplate turning to such clinics for succor, and for state and federal regulators and law enforcement agencies that should be riding herd on thembut have almost universally given them a pass. Oz calls on the Food and Drug Administration and other regulators to step in and stop this now, thats how bad its become.

Weve been critical of Dr. Oz in the past for purveying untested medical nostrums, as have many other critics. But his investigation of the stem cell clinics is a model of public service. He musters his entire arsenal of crowd-pleasing techniques his forceful, impassioneddelivery, his cultivated aura of medical authority, and his credibility with his audience to the best purpose.

The investigation is the product of the shows so-calledmedical unit and its chief of staff, Michael Crupain, a medical doctor and public health specialist who was hired from Consumer Reports about a year and a half ago. At one point during his research for the program Crupain dialed in to a webinar in which prospective patients were recruited by a clinic. It was like watching someone sell a time-share, he told me an observation that made it into the show.

The three segments, which take up about half of Tuesdays scheduled program, include undercover visits to clinics in New York by Elizabeth Leamy, a reporter on the program, along with a former patient. At one point we see a clinic employee claim that hestreated 44 patients for multiple sclerosis, and every single patient had vast improvement. The investigators are pitched $15,000 treatments and encouraged to spread it out on their credit cards. (No insurer will cover these untested and unproven therapies.) One promoter seen on tape acknowledges to the undercover team, We dont know the exact mechanism of everything we do, but counselsthem, We just know that it works, we use it. If it works and its safe [and] its reasonable in cost, you know, why not?

Why not, indeed? Because the targets of these pitches are at the end of their rope, vulnerable to scamsters,and often have to make immense sacrifices to pay the fees. Doctors and others can prey on their vulnerability, Oz observes.

Oz displays a list of the conditions the clinics claim to treat joint pain, autism, Parkinsons, Alzheimers, stroke, emphysema, and blindness, among many others. He explains that its impossible for a one-size-fits-all treatment to cure them all: It defies basic medical know-how, which means they are not telling us the truth. He lucidly describes their supposed technique, which involves extracting stem cells from the patients by liposuction, separating the stem cells by centrifuge and treating them with some sort of enzyme, then reinjecting them in the patients body and waiting for the concoction to do its magic.

He offers a withering assessment of doctors who claim to be engaged in clinical trials of stem cell treatments butask you to give money upfront and mortgage your house and borrow fromyour friends credit cards thats not how medicine should be practiced.

Oz is assisted by talk show host and multiple sclerosis patient Montel Williams and Sally Temple, a stem cell scientistwho is president of theInternational Society for Stem Cell Research. Temple explains that real research into stem cell treatments takes years and aims to develop treatments that can receive FDA approval. She quite properly underscoresthe dangerto legitimate research posed by bogus clinics offering medically dubious treatments.

Theyre saying they can cure a whole host of diseases, and we know they cant, she says. We are really concerned that its going to undermine the genuinely good work thats being done.

Crupain considers the stem cell investigation to be Dr. Oz at his best. Hes right.

Keep up to date with Michael Hiltzik. Follow@hiltzikmon Twitter, see hisFacebook page, or emailmichael.hiltzik@latimes.com.

Return to Michael Hiltzik's blog.

Novel Nanofiber Matrix Improves Stem Cell Production – R & D Magazine

By adminFebruary 14, 2017Embryonic Stem Cells

A new nanofiber-on-microfiber matrix could lead to more and better quality stem cells for disease treatment and regenerative therapies.

The matrix, produced by researchers from Kyoto University in Japan, is made of gelatin nanofibers on a synthetic polymer microfiber mesh and may provide a better way to culture large quantities of healthy human stem cells.

Researchers have been developing 3D culturing systems to allow human pluripotent stem cells (hPSC) to grow and interact with their surroundings in all three dimensions, as they would inside the human body, rather than in two dimensions like they do in a petri dish.

Pluripotent stems cells can differentiate into any type of adult cell and have potential for tissue regeneration therapies, treating diseases and for research.

The majority of 3D culturing systems have limitations and result in low quantities and quality of cultured cells.

The research team was able to fabricate gelatin nanofibers onto a microfiber sheet made of synthetic, biodegradable polyglycolic acid. They then seeded human embryonic stem cells onto the matrix in a cell culture medium.

The matrix allowed for an easy exchange of growth factors and supplements from the culture medium to the cells.

The stem cells also adhered well to the matrix, resulting in robust cell growth. After four days of culture more than 95 percent of the cells grew and formed colonies.

The research team also scaled up the process by designing a gas-permeable cell culture bag in which multiple cell-loaded, folded fiber-to-fiber matrices were placed.

The system was designed so that minimal changes were needed to the internal environment, which reduced the amount of stress placed on the cells. This also yielded a large number of cells compared to conventional 2D and 3D culture methods.

Our method offers an efficient way to expand hPSCs of high quality within a shorter term, the research team wrote in a statement. Additionally, as nanofiber matrices are advantageous for culturing other adherent cells, including hPSC-derived differentiated cells, FF matrix might be applicable to the large-scale production of differentiated functional cells for various applications.

According to the study, clinical-grade scaffolds and high-quality hPSCs are required for cell expansion as well as easy handling and manipulation of the products.

Current hPSC culture methods do not fulfill these requirements because of a lack of proper extracellular matrices (ECM) and cell culture wares.

The layered nano-on-micro fibrous cellular matrix mimicking ECM enables easy handling and manipulation of cultured cells.

The results show that the matrix supports effective hPSC culture with maintenance of their pluripotency and normal chromosomes over two months, as well as effective scaled-up expansion with fold increases of 54.115.6 and 40.48.4 in cell number per week for H1 human embryonic stem cells and 253G1 human induced pluripotent stem cells, respectively.

The study was published in Biomaterials.

Continued here:
Novel Nanofiber Matrix Improves Stem Cell Production - R & D Magazine

Type 1 diabetes: Reprogramming liver cells may lead to new treatments – Medical News Today

By adminFebruary 14, 2017Uncategorized

Researchers have discovered a way to reprogram mouse liver cells into precursor pancreatic cells by changing the expression of a single gene. They suggest that the finding is an important step toward showing that reprogramming liver cells might offer a way forward for the treatment of type 1 diabetes in humans.

The team - led by researchers from the Max Delbrck Center for Molecular Medicine in Berlin, Germany - reports the study in the journal Nature Communications.

Diabetes is a chronic disease that develops either when the body cannot make enough insulin, or when it cannot effectively use the insulin that it does make. Insulin is a hormone that regulates blood sugar, or glucose, and it helps to convert glucose from food into energy for cells.

Uncontrolled diabetes leads to high blood sugar, or hyperglycemia, which over time causes serious damage to many parts of the body, including the heart, blood vessels, nerves, eyes, and kidneys.

In the United States, an estimated 29.1 million people have diabetes, including 8.1 million who are undiagnosed.

The most common type of diabetes is type 2, in which the body cannot use insulin effectively. Type 1 diabetes, in which the body does not make enough insulin, accounts for around 5 percent of diabetes cases in adults.

The new study is likely to interest researchers developing treatments for type 1 diabetes. In people with type 1 diabetes, the immune system attacks the insulin-producing beta cells of the pancreas.

Researchers in regenerative medicine are exploring ways to generate new populations of pancreatic beta cells as a possible avenue for the treatment of type 1 diabetes.

Fast facts about type 1 diabetes

Learn more about type 1 diabetes

The new study concerns a method called cell reprogramming, in which it is possible to convert one type of cell into another type of cell, by tweaking genes.

An obvious source of cells for reprogramming into insulin-producing beta cells might be other types of cell in the pancreas.

In their study paper, the researchers mention other research that shows such pancreatic cells display a high degree of the necessary "cellular plasticity."

However, the researchers chose to focus on liver cells because, from a clinical perspective, they offer important advantages over pancreatic cells; for example, they are more accessible and abundant.

They also cite studies that have partially corrected hyperglycemia in diabetic mice by reprogramming liver cells into pancreatic beta cells.

The new study shows how just by changing the expression of a single gene called TGIF2, the team was able to coax mouse liver cells to take on a less specialized state and then stimulate them to develop into cells with pancreatic features.

When the researchers transplanted the modified cells into diabetic mice, the animals' blood sugar levels improved, suggesting the cells were behaving in a way similar to pancreatic beta cells.

The researchers identified TGIF2 (Three-Amino-acid-Loop-Extension homeobox TG-interacting factor 2) by running gene expression profiling tests on immature liver and pancreas cells isolated from mouse embryos as the cells differentiated toward their particular cell fates.

They found that at a particular differentiation branchpoint, the expression of TGIF2 changes in opposite directions as the cells commit to either liver or pancreatic fates.

The authors note that their study shows that "TGIF2 is a developmental regulator of pancreas versus liver fate decision," and when expressed in adult mouse liver cells, it suppresses the transcription program for liver cells and induces a subset of pancreatic genes.

There is still a lot of work to do to investigate whether the results with mice translate to humans. The team has already started working on human liver cells.

"There are differences between mice and humans, which we still have to overcome. But we are well on the path to developing a 'proof of concept' for future therapies."

Senior author Dr. Francesca M. Spagnoli, Max Delbrck Center

Learn how type 1 diabetes kills some insulin-producing cells but not others.

Originally posted here:
Type 1 diabetes: Reprogramming liver cells may lead to new treatments - Medical News Today

Area medical clinic offers regenerative cell treatment – RiverBender.com

By adminFebruary 14, 2017Uncategorized

WOOD RIVER - There is an alternative to using prescription drugs or resorting to joint surgery for pain relief. Dr. Michael Harbison, DC, MCS-P, CCCPC, of iCAN Clinic in Wood River, Illinois, is holding an informational seminar on the use of regenerative cellular medicine for pain relief at 7 p.m. on Tuesday, February 21st, at his clinic located at 203 E. Ferguson Avenue in Wood River.

Harbison, who recently changed the name of his clinic from AlignLife of Wood River to iCAN Clinic, researched regenerative cellular medicine and, based on significant advancements in stem cell research, realized the importance of stem cell injections for treating people suffering from inflammation, reduced mobility, sports injuries, tissue and ligament damage or chronic pain.

Our mission at iCAN Clinic is to help our patients unlock the God given potential of their body. said Harbison. Stem cells are the bodys master cells and can develop into all other cells, so not only is pain relieved, it is possible new cartilage, ligaments and bone can be regenerated. Stem cell therapy gives our patients a choice other than surgery and/or a regimen of possibly addictive narcotics. Harbison went on to say Thats an easy choice to make given that this therapy has been known provide full relief to patients after only one treatment. Generally, the repair process begins immediately and the repair process can continue for up to eight additional months from the date of the initial procedure.

But it wasnt until Dr. Harbison found an ethical source of stem cells that he decided to offer the therapy. Harbison said that the Stem Cell Institute of America provides stem cells that were taken from placentas that were donated by mothers after the birth of their child. There was no destruction of life in the process of obtaining these stem cells.

Harbison is excited about offering the new stem cell therapy because hes seen its results.

Seating for the Tuesday, February 21st, seminar is limited so reservations are required. To reserve a seat for the 7:00 p.m. program, contact iCAN Clinic at 618-254-2273.

Stem Cell Therapy Seminar Tuesday February 21, 7:00 PM

iCAN Clinic

203 E Ferguson Ave.

Wood River, IL 62095

618-254-2273

http://www.iCANClinic.org

Send your news tips to news@riverbender.com or on twitter @RiverBenderNews

Purchase photos from this article Print Version Submit a News Tip

Share this story with your friends and family.

Here is the original post:
Area medical clinic offers regenerative cell treatment - RiverBender.com